Ken Griffin Accolade, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$9.22 - $15.02 $16,596 - $27,036	1,800 Added 1.14%	159,100 $1.67 Million
Q4 2023 Feb 14, 2024	BUY	$6.5 - $12.85 $617,500 - $1.22 Million	95,000 Added 152.49%	157,300 $1.89 Million
Q3 2023 Nov 14, 2023	SELL	$10.45 - $15.02 $78,375 - $112,650	-7,500 Reduced 10.74%	62,300 $659,000
Q2 2023 Aug 14, 2023	SELL	$10.52 - $16.06 $350,316 - $534,798	-33,300 Reduced 32.3%	69,800 $940,000
Q1 2023 May 15, 2023	BUY	$7.32 - $14.38 $65,148 - $127,982	8,900 Added 9.45%	103,100 $1.48 Million

Q4 2022 Feb 14, 2023	SELL	$7.19 - $13.16 $70,462 - $128,968	-9,800 Reduced 9.42%	94,200 $733,000
Q3 2022 Nov 14, 2022	BUY	$0.0 - $12.8 $0 - $952,320	74,400 Added 251.35%	104,000 $1.19 Million

171

68.5M

163K

492K

Ticker ACCD
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 71,938,896
Market Cap $254M
Description
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.